Kensuke Nakazawa

795 citations
30 papers · 489 indexed · h-index 8
Topics
Lung Cancer Research Studies (8 papers)Lung Cancer Treatments and Mutations (7 papers)Neuroendocrine Tumor Research Advances (6 papers)

In The Last Decade

Kensuke Nakazawa

26 papers receiving 481 citations

Peers

Kensuke Nakazawa
Comparison fields: 5 of 64
  • Oncology 279
  • Pulmonary and Respiratory Medicine 273
  • Molecular Biology 98
  • Epidemiology 89
  • Cancer Research 67
Replace M Paesmans with:
M Paesmans Belgium
Tetsuro Tamamoto Japan
Shinichiro Shimamatsu Japan
Rebecca Tay United Kingdom
Manpreet Chadha United States
Yang Lv China
G. Stathopoulos Greece
M. Rossi Italy
Antonio Soriano Spain
Kensuke Nakazawa relative to M Paesmans Belgium M Paesmans's profile →
Citations per field
00.5×7.4×
M Paesmans · 1×
Citations per year

Countries citing papers authored by Kensuke Nakazawa

Since Specialization
Citations

This map shows the geographic impact of Kensuke Nakazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Nakazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Nakazawa more than expected).

Fields of papers citing papers by Kensuke Nakazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Nakazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Nakazawa. The network helps show where Kensuke Nakazawa may publish in the future.

Co-authorship network of co-authors of Kensuke Nakazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Nakazawa. A scholar is included among the top collaborators of Kensuke Nakazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Nakazawa. Kensuke Nakazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 5
5 6
6 6
7 5
8 0
9 3
10 5
11 12
12 237
13 8
14 3
15 6
16 1
17 114
18 12
19 8
20 2

About Kensuke Nakazawa

Kensuke Nakazawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 30 papers that have together received 489 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Oncology (279 citations), Pulmonary and Respiratory Medicine (273 citations) and Cancer Research (67 citations). Kensuke Nakazawa has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Nobuyuki Hizawa, Hiroaki Satoh, Koichi Kurishima, Tomohiro Tamura, Hiroichi Ishikawa, Katsunori Kagohashi, Toshihiro Shiozawa, Hiroko Watanabe, Shinya Sato and Ikuo Sekine. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer and Medical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026